Intellectual Property Rights Publications

Publications

Intellectual Property Rights

All 21

Aligning Intellectual Property Rights with Open Science

ALLEA Statement on Vaccination Bottlenecks in the Global South and a Patent Waiver for Covid-19 Vaccines

ALLEA Statement on The European Commission Public Consultation on the Data Act

Towards implementing the European Open Science Cloud – IPR and other strategic considerations

The Need for Intellectual Property Rights Strategies at Academic Institutions

ALLEA Response to Plan S

The Ownership and Protection of Multinational Inventions – in particular Inventions Resulting from Publicly Funded Research

The Text and Data Mining Exception and the Enhancement of Access to Scientific Information in Europe

ALLEA Statement on Patentability of Inventions Involving Human “Embryonic” Pluripotent Stem Cells in Europe

ALLEA Statement on Patent-Related Aspects of CRISPR-Cas Technology

ALLEA Statement on the Status of the Patent System of the European Union

Supplementary Statement on Enhancement of Open Access to Scientific Publications in Europe

ALLEA Statement on Enhancement of Open Access to Scientific Publications in Europe

Patentability and Research Funding relating to embryonic Stem Cells (e-SCs)

Statement Adopted on the Occasion of a Conference on “Grace Period“ in Kiev, 10 October 2013

Patentability of Inventions Involving Human Embryonic Pluripotent Stem Cells in Europe of May 2011 and the Judgment of the Court of European Communities (Grand Chamber) of 18 October 2011 in Case C-34/10

Open Science for the 21st century

The Future Patent System of the European Union

Opportunities and Risks: the Digitisation of Books and the Google Book Settlement

Common Strategic Framework for EU Research & Innovation Funding

Patenting of Inventions Involving Human Embryonic Pluripotent Stem Cells in Europe